Created in 1990, Recordati Rare Diseases is a pharmaceutical company committed to developing and providing treatment for patients with rare diseases.

Our specialty rare disease products are marketed directly by Recordati Rare Diseases in Europe, the Middle East, the U.S.A., Canada, Russia, Japan and Australia, in some Latin American countries, and through selected partners in other parts of the world.

Thanks to a specialised production, packaging and distribution system developed for our products, our dedicated team of specialists are able to support patients in their home countries.

Recordati Rare Diseases is committed to supporting families affected by rare diseases through the research and development of new therapies and the distribution of specific scientific knowledge throughout the medical community.